Polymyalgia Rheumatica Global Market Report 2025

Name: Polymyalgia Rheumatica Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Download Sample Buy Report

Global Polymyalgia Rheumatica Market Report 2025

Polymyalgia Rheumatica Global Market Report 2025 - By Treatment (Corticosteroids, Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Biologics), By Route Of Administration (Oral, Intravenous, Subcutaneous), By Patient Type (Adult, Geriatric, Periatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Polymyalgia Rheumatica Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : April 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Polymyalgia Rheumatica Global Market Report 2025

Proud Members Of

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Polymyalgia Rheumatica Market?

Polymyalgia rheumatica (PMR) is an inflammatory disorder that primarily affects older adults, causing muscle pain and stiffness, particularly in the shoulders, hips, and neck. It is characterized by aching and swelling in the muscles around the shoulders and hips, leading to difficulty in movement and daily activities.

The main treatment types of polymyalgia rheumatica are corticosteroids, nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, and biologics. Corticosteroids are the primary treatment for polymyalgia rheumatica (PMR), reducing inflammation and alleviating symptoms by mimicking adrenal hormones. It is administered through various routes of administration, such as oral, intravenous, and subcutaneous, for several patient types, such as adult, geriatric, and pediatric. It is distributed through various distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

Polymyalgia Rheumatica Market Size and growth rate 2025 to 2029: Graph

What Is The Polymyalgia Rheumatica Market Size 2025 And Growth Rate?

The polymyalgia rheumatica market size has grown strongly in recent years. It will grow from $1.28 billion in 2024 to $1.36 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to rising awareness among healthcare practitioners, rising use of corticosteroids, growth in specialty clinics, the introduction of biologic therapies, and rising healthcare budgets.

What Is The Polymyalgia Rheumatica Market Growth Forecast?

The polymyalgia rheumatica market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to the growing adoption of biologics, expansion of precision medicine, accelerated drug approvals, broader reimbursements, and expansion of clinical trials. Major trends in the forecast period include the development of combination therapies, advancements in personalized medicine, the development of precision medicine, the integration of electronic health records, and advancements in biomarkers.

Book your 30 minutes free consultation with our research experts

How Is The Polymyalgia Rheumatica Market Segmented?

The polymyalgia rheumatica market covered in this report is segmented –

1) By Treatment: Corticosteroids, Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Biologics

2) By Route Of Administration: Oral, Intravenous, Subcutaneous

3) By Patient Type: Adult, Geriatric, Periatric

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Corticosteroids: Prednisone, Methylprednisolone, hydrocortisone, Dexamethasone

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Aspirin, Celecoxib

3) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Leflunomide, Sulfasalazine, Hydroxychloroquine

4) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin-6 (IL-6) Inhibitors, B-Cell Inhibitors, Janus Kinase (JAK) Inhibitors

What Is Driving The Polymyalgia Rheumatica Market? Rising Demand For Personalized Medicine Driving Growth In The Market Due To Tailored Treatments And Advancements In Genetic Research

The rise in demand for personalized medicine is expected to propel the growth of the polymyalgia rheumatica market going forward. Personalized medicine is medical treatment tailored to an individual’s genetic profile, lifestyle, and specific health conditions for more effective outcomes. The demand for personalized medicine is driven by advancements in genetic research, growing patient expectations for tailored treatments, and improvements in diagnostic technologies. Genetic research provided a deeper understanding of individual genetic variations, allowing for more customized treatments targeting specific genetic markers. Personalized medicine can help select drugs that are most likely effective based on the patient’s characteristics, leading to a more effective and safer treatment plan. For instance, in February 2024, according to the Personalised Medicine Coalition, a US-based hospital and health care organization, in 2023, the Food and Drug Administration approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the rise of personalized medicine is driving the growth of the polymyalgia rheumatica market.

What Is Driving The Polymyalgia Rheumatica Market? Growth In Telemedicine Services Fueling The Expansion Of The Market Due To Increasing Convenience And Remote Care

The growth in telemedicine services is expected to propel the growth of the polymyalgia rheumatica market going forward. Telemedicine services use digital communication technologies, such as video calls, phone calls, and online messaging, to provide remote medical consultations, diagnoses, treatment, and follow-up care to patients without the need for in-person visits. The growth in telemedicine services is due to increasing demand for convenient healthcare options and cost-effective healthcare solutions. Patients increasingly seek convenience, especially for non-urgent consultations, which telemedicine offers by eliminating the need for in-person visits. The growth of telemedicine services supports polymyalgia rheumatica (PMR) by enabling remote monitoring of symptoms, medication management, and regular follow-ups, which are crucial for managing chronic pain and inflammation. For instance, in November 2024, according to the Australian Bureau of Statistics, an Australia-based government agency, in 2022-23, people using telehealth consultation was 87.7%, which reached 89.2% in 2023-24. Therefore, the growth in telemedicine services is driving the growth of the polymyalgia rheumatica market.

Who Are The Major Players In The Global Polymyalgia Rheumatica Market?

Major companies operating in the polymyalgia rheumatica market are AbbVie Inc., Sanofi S.A., Eli Lilly and Co., Regeneron Pharmaceuticals Inc., Mount Sinai, NYU Langone Health, Mayo Foundation for Medical Education and Research, Hartford HealthCare, Horizon Therapeutics plc, Massachusetts General Hospital, Brigham and Women's Hospital, Stanford Health Care, University Hospitals Bristol NHS Foundation Trust, Circle Health Group Ltd., Siloam Hospital, UC San Diego Health, Vejthani Hospital, Sparrow Pharmaceuticals Inc., Johns Hopkins Arthritis Center, Upstate University Hospital

What Are The Key Trends Of The Global Polymyalgia Rheumatica Market? FDA Approval Of Advanced IL-6 Receptor Blocker Offers New Treatment For Polymyalgia Rheumatica

Major companies operating in the polymyalgia rheumatica market are focusing on developing advanced drugs, such as interleukin-6 (IL-6) receptor blockers, to provide more targeted and effective treatment options. Interleukin-6 (IL-6) receptor blockers are biological drugs that inhibit IL-6, a key pro-inflammatory cytokine in autoimmune diseases. By blocking IL-6, these treatments reduce inflammation and improve symptoms, enhancing the quality of life for PMR patients. For instance, in February 2023, Regeneron Pharmaceuticals, Inc., a US-based biotechnology company, and Sanofi, a France-based healthcare company, announced the Food and Drug Administration (FDA) approved Kevzara (sarilumab) for treating polymyalgia rheumatica (PMR) in adults who haven't responded well to corticosteroids or can't tolerate tapering off them. Kevzara, the first and only biologic approved for this condition, works by inhibiting IL-6-mediated signaling. The approval was based on a study where 28.3% of patients on sarilumab achieved sustained remission at week 52, compared to 10.3% on placebo2. Kevzara is administered via subcutaneous injection once every two weeks and is also approved for treating moderately to severely active rheumatoid arthritis. Sanofi's stock (SNY) is currently priced at $54.13 on the NASDAQ.

What Is The Regional Outlook For The Global Polymyalgia Rheumatica Market?

Asia-Pacific was the largest region in the polymyalgia rheumatica market in 2024. The regions covered in the polymyalgia rheumatica market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the polymyalgia rheumatica market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Polymyalgia Rheumatica Market?

The polymyalgia rheumatica market consists of revenues earned by entities by providing services such as medication management, pain management, laboratory testing, and nutritional counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymyalgia rheumatica market includes sales of disease-modifying anti-rheumatic drugs, calcium and vitamin D supplements, assistive devices, and physical therapy aids. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Polymyalgia Rheumatica Industry?

The polymyalgia rheumatica market research report is one of a series of new reports from The Business Research Company that provides polymyalgia rheumatica market statistics, including the polymyalgia rheumatica industry global market size, regional shares, competitors with the polymyalgia rheumatica market share, detailed polymyalgia rheumatica market segments, market trends, and opportunities, and any further data you may need to thrive in the polymyalgia rheumatica industry. This polymyalgia rheumatica market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Polymyalgia Rheumatica Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.36 billion
Revenue Forecast In 2034	$1.73 billion
Growth Rate	CAGR of 6.2% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The polymyalgia rheumatica market covered in this report is segmented – 1) By Treatment: Corticosteroids, Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Biologics 2) By Route Of Administration: Oral, Intravenous, Subcutaneous 3) By Patient Type: Adult, Geriatric, Periatric 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Corticosteroids: Prednisone, Methylprednisolone, Hydrocortisone, Dexamethasone 2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Aspirin, Celecoxib 3) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Leflunomide, Sulfasalazine, Hydroxychloroquine 4) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin-6 (IL- 6) Inhibitors, B-Cell Inhibitors, Janus Kinase (JAK) Inhibitors
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	AbbVie Inc., Sanofi S.A., Eli Lilly and Co., Regeneron Pharmaceuticals Inc., Mount Sinai, NYU Langone Health, Mayo Foundation for Medical Education and Research, Hartford HealthCare, Horizon Therapeutics plc, Massachusetts General Hospital, Brigham and Women's Hospital, Stanford Health Care, University Hospitals Bristol NHS Foundation Trust, Circle Health Group Ltd., Siloam Hospital, UC San Diego Health, Vejthani Hospital, Sparrow Pharmaceuticals Inc., Johns Hopkins Arthritis Center, Upstate University Hospital
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Polymyalgia Rheumatica Market Characteristics

3. Polymyalgia Rheumatica Market Trends And Strategies

4. Polymyalgia Rheumatica Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Polymyalgia Rheumatica Growth Analysis And Strategic Analysis Framework

5.1. Global Polymyalgia Rheumatica PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Polymyalgia Rheumatica Market Growth Rate Analysis

5.4. Global Polymyalgia Rheumatica Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Polymyalgia Rheumatica Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Polymyalgia Rheumatica Total Addressable Market (TAM)

6. Polymyalgia Rheumatica Market Segmentation

6.1. Global Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Corticosteroids

Nonsteroidal Anti-Inflammatory Drugs

Disease-Modifying Antirheumatic Drugs

Biologics

6.2. Global Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Subcutaneous

6.3. Global Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adult

Geriatric

Periatric

6.4. Global Polymyalgia Rheumatica Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.5. Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prednisone

Methylprednisolone

Hydrocortisone

Dexamethasone

6.6. Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ibuprofen

Naproxen

Aspirin

Celecoxib

6.7. Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Methotrexate

Leflunomide

Sulfasalazine

Hydroxychloroquine

6.8. Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tumor Necrosis Factor (TNF) Inhibitors

Interleukin-6 (IL-6) Inhibitors

B-Cell Inhibitors

Janus Kinase (JAK) Inhibitors

7. Polymyalgia Rheumatica Market Regional And Country Analysis

7.1. Global Polymyalgia Rheumatica Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Polymyalgia Rheumatica Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Polymyalgia Rheumatica Market

8.1. Asia-Pacific Polymyalgia Rheumatica Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Polymyalgia Rheumatica Market

9.1. China Polymyalgia Rheumatica Market Overview

9.2. China Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Polymyalgia Rheumatica Market

10.1. India Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Polymyalgia Rheumatica Market

11.1. Japan Polymyalgia Rheumatica Market Overview

11.2. Japan Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Polymyalgia Rheumatica Market

12.1. Australia Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Polymyalgia Rheumatica Market

13.1. Indonesia Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Polymyalgia Rheumatica Market

14.1. South Korea Polymyalgia Rheumatica Market Overview

14.2. South Korea Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Polymyalgia Rheumatica Market

15.1. Western Europe Polymyalgia Rheumatica Market Overview

15.2. Western Europe Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Polymyalgia Rheumatica Market

16.1. UK Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Polymyalgia Rheumatica Market

17.1. Germany Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Polymyalgia Rheumatica Market

18.1. France Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Polymyalgia Rheumatica Market

19.1. Italy Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Polymyalgia Rheumatica Market

20.1. Spain Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Polymyalgia Rheumatica Market

21.1. Eastern Europe Polymyalgia Rheumatica Market Overview

21.2. Eastern Europe Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Polymyalgia Rheumatica Market

22.1. Russia Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Polymyalgia Rheumatica Market

23.1. North America Polymyalgia Rheumatica Market Overview

23.2. North America Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Polymyalgia Rheumatica Market

24.1. USA Polymyalgia Rheumatica Market Overview

24.2. USA Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Polymyalgia Rheumatica Market

25.1. Canada Polymyalgia Rheumatica Market Overview

25.2. Canada Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Polymyalgia Rheumatica Market

26.1. South America Polymyalgia Rheumatica Market Overview

26.2. South America Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Polymyalgia Rheumatica Market

27.1. Brazil Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Polymyalgia Rheumatica Market

28.1. Middle East Polymyalgia Rheumatica Market Overview

28.2. Middle East Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Polymyalgia Rheumatica Market

29.1. Africa Polymyalgia Rheumatica Market Overview

29.2. Africa Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Polymyalgia Rheumatica Market Competitive Landscape And Company Profiles

30.1. Polymyalgia Rheumatica Market Competitive Landscape

30.2. Polymyalgia Rheumatica Market Company Profiles

30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Eli Lilly and Co. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Mount Sinai Overview, Products and Services, Strategy and Financial Analysis

31. Polymyalgia Rheumatica Market Other Major And Innovative Companies

31.1. NYU Langone Health

31.2. Mayo Foundation for Medical Education and Research

31.3. Hartford HealthCare

31.4. Horizon Therapeutics plc

31.5. Massachusetts General Hospital

31.6. Brigham and Women's Hospital

31.7. Stanford Health Care

31.8. University Hospitals Bristol NHS Foundation Trust

31.9. Circle Health Group Ltd.

31.10. Siloam Hospital

31.11. UC San Diego Health

31.12. Vejthani Hospital

31.13. Sparrow Pharmaceuticals Inc.

31.14. Johns Hopkins Arthritis Center

31.15. Upstate University Hospital

32. Global Polymyalgia Rheumatica Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Polymyalgia Rheumatica Market

34. Recent Developments In The Polymyalgia Rheumatica Market

35. Polymyalgia Rheumatica Market High Potential Countries, Segments and Strategies

35.1 Polymyalgia Rheumatica Market In 2029 - Countries Offering Most New Opportunities

35.2 Polymyalgia Rheumatica Market In 2029 - Segments Offering Most New Opportunities

35.3 Polymyalgia Rheumatica Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Polymyalgia Rheumatica Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Polymyalgia Rheumatica Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Polymyalgia Rheumatica Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: AbbVie Inc. Financial Performance

Table 80: Sanofi S.A. Financial Performance

Table 81: Eli Lilly and Co. Financial Performance

Table 82: Regeneron Pharmaceuticals Inc. Financial Performance

Table 83: Mount Sinai Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Polymyalgia Rheumatica Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Polymyalgia Rheumatica Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Polymyalgia Rheumatica Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: AbbVie Inc. Financial Performance

Figure 80: Sanofi S.A. Financial Performance

Figure 81: Eli Lilly and Co. Financial Performance

Figure 82: Regeneron Pharmaceuticals Inc. Financial Performance

Figure 83: Mount Sinai Financial Performance

How is the Allergy Diagnostics Market Poised for Growth: Trends and Opportunities Through 2034

Future Outlook of the Ambulatory Electronic Medical Records Market: Growth, Trends, and Emerging Opportunities Explored

Antimicrobial Susceptibility Testing Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

Assisted Reproductive Technology Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

How is the Bed Monitoring System & Baby Monitoring System Market Poised for Growth: Trends and Opportunities Through 2034

Growth Opportunities and Trends in the Biopharmaceutical CMO Market: Key Insights for 2025-2034

How Will the Bipolar Disorder Therapeutics Market Grow? Key Trends and Opportunities for 2025 and Beyond

Key Trends and Insights into the Bleeding Disorders Treatment Market: Growth Rate and Opportunities to 2034

Bipolar Disorder Therapeutics Global Market Report 2025 – By Drug Class (Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs), By Mechanism (Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

HPV Associated Disorders Global Market Report 2025 – By Indication (Cervical Intraepithelial Neoplasia (CIN), Cervical Cancer, Anal Intraepithelial Neoplasia (AIN), Anal Cancer, Genital Warts, Other Indications), By Therapy (Prevention, Treatment), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Bleeding Disorders Treatment Global Market Report 2025 – By Treatment (Desmopressin (DDAVP), Hormone Replacement Therapy, Contraceptives, Anti-Fibrinolytic or Clot-Stabilizing Drugs, Fibrin Sealants, Drugs Applied To Cuts, Pipeline Analysis), By Disease Type (Hemophilia A, Hemophilia B, Von willebrand disease, Liver disease, Other Disease Types), By End User (Hospitals, Clinics, Specialty Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Post-Traumatic Stress Disorder Therapeutics Global Market Report 2025 – By Drug Class (Antidepressants, Anti-Anxiety, Antihypertensive, Monoamine Oxidase (MAOs), Antipsychotics Or Second Generation Antipsychotics (SGOs), Beta-Blockers, Other Classes), By Age Group (Pediatric, Geriatric, Adult), By End User (Mental Health Center, Hospitals, Outpatient Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Generic Musculoskeletal Disorders Drugs Global Market Report 2025 – By Treatment Type (Medication, Therapy, Surgery, Other Treatment Types), By Disorder Type (Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Fibromyalgia, Other Disorder Types), By Route of Administration (Oral, Parenteral, Other Routes), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Headache Disorders Global Market Report 2025 – By Type (Migraine, Tension-Type Headache, Cluster Headache, Medication-Overuse Headache, Other Types), By Treatment (Medication, Heat Therapy, Diet Changes, Acupuncture, Oxygen Therapy), By Diagnosis (Complete Blood Count, Skull X-Rays, Sinus X-Rays, CT Scan, Magnetic Resonance Imaging (MRI)), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By End-User (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Myeloproliferative Disorders Drugs Global Market Report 2025 – By Type (Primary Myelofibrosis, Polycythemia Vera (PV), Essential Thrombocythemia (ET), Chronic Eosinophilic Leukemia Or Hyper eosinophilic Syndrome (HES), Systemic Masto cytosis (SM)), By Drug Type (JAK2 Inhibitors, Anti-Neoplastics, Demethylation Agents, Imatinib Mesylate, Other Drug Types), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacy, Retail Stores, Drug Stores) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hyperpigmentation Disorder Treatment Global Market Report 2025 – By Treatment Type (Cosmeceuticals, Laser Therapy, Chemical Peels, Microdermabrasion, Phototherapy, Other Treatments), By Disease Indication (Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines, Other Disease Indications), By End-Users (Hospitals, Esthetic Clinics And Dermatology Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Polymyalgia Rheumatica market?

How will the Polymyalgia Rheumatica market drivers and restraints affect the market dynamics? What forces will shape the Polymyalgia Rheumatica industry going forward?

The Polymyalgia Rheumatica market major growth driver - Rising Demand For Personalized Medicine Driving Growth In The Market Due To Tailored Treatments And Advancements In Genetic Research. For further insights on the Polymyalgia Rheumatica market, request a sample here

What is the forecast market size or the forecast market value of the Polymyalgia Rheumatica market?

The Polymyalgia Rheumatica market size has grown strongly in recent years. The polymyalgia rheumatica market size has grown strongly in recent years. It will grow from $1.28 billion in 2024 to $1.36 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to rising awareness among healthcare practitioners, rising use of corticosteroids, growth in specialty clinics, the introduction of biologic therapies, and rising healthcare budgets. The polymyalgia rheumatica market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to the growing adoption of biologics, expansion of precision medicine, accelerated drug approvals, broader reimbursements, and expansion of clinical trials. Major trends in the forecast period include the development of combination therapies, advancements in personalized medicine, the development of precision medicine, the integration of electronic health records, and advancements in biomarkers. For further insights on the Polymyalgia Rheumatica market, request a sample here

How is the Polymyalgia Rheumatica market segmented?

The Polymyalgia Rheumatica market covered in this report is segmented –
1) By Treatment: Corticosteroids; Nonsteroidal Anti-Inflammatory Drugs; Disease-Modifying Antirheumatic Drugs; Biologics
2) By Route Of Administration: Oral; Intravenous; Subcutaneous
3) By Patient Type: Adult; Geriatric; Periatric
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Subsegments:
1) By Corticosteroids: Prednisone; Methylprednisolone; Hydrocortisone; Dexamethasone
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen; Naproxen; Aspirin; Celecoxib
3) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate; Leflunomide; Sulfasalazine; Hydroxychloroquine
4) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin-6 (IL-6) Inhibitors; B-Cell Inhibitors; Janus Kinase (JAK) Inhibitors For further insights on the Polymyalgia Rheumatica market, request a sample here

Which region has the largest share of the Polymyalgia Rheumatica market? What are the other regions covered in the report?

Who are the major players in the Polymyalgia Rheumatica market?

What are the key trends in the Polymyalgia Rheumatica market?

Major trends in the Polymyalgia Rheumatica market include FDA Approval Of Advanced IL-6 Receptor Blocker Offers New Treatment For Polymyalgia Rheumatica. For further insights on the Polymyalgia Rheumatica market, request a sample here.

What are the major opportunities in the Polymyalgia Rheumatica market? What are the strategies for the Polymyalgia Rheumatica market?

For detailed insights on the major opportunities and strategies in the Polymyalgia Rheumatica market, request a sample here.

How does the Polymyalgia Rheumatica market relate to the overall economy and other similar markets?

For detailed insights on Polymyalgia Rheumatica's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Polymyalgia Rheumatica industry?

For detailed insights on the mergers and acquisitions in the Polymyalgia Rheumatica industry, request a sample here.

What are the key dynamics influencing the Polymyalgia Rheumatica market growth? SWOT analysis of the Polymyalgia Rheumatica market.

For detailed insights on the key dynamics influencing the Polymyalgia Rheumatica market growth and SWOT analysis of the Polymyalgia Rheumatica industry, request a sample here.

Polymyalgia Rheumatica Global Market Report 2025

Polymyalgia Rheumatica Global Market Report 2025

Market Insights

Related Reports

What Is Covered Under Polymyalgia Rheumatica Market?

What Is The Polymyalgia Rheumatica Market Size 2025 And Growth Rate?

What Is The Polymyalgia Rheumatica Market Growth Forecast?

How Is The Polymyalgia Rheumatica Market Segmented?

What Is Driving The Polymyalgia Rheumatica Market? Rising Demand For Personalized Medicine Driving Growth In The Market Due To Tailored Treatments And Advancements In Genetic Research

What Is Driving The Polymyalgia Rheumatica Market? Growth In Telemedicine Services Fueling The Expansion Of The Market Due To Increasing Convenience And Remote Care

Who Are The Major Players In The Global Polymyalgia Rheumatica Market?

What Are The Key Trends Of The Global Polymyalgia Rheumatica Market? FDA Approval Of Advanced IL-6 Receptor Blocker Offers New Treatment For Polymyalgia Rheumatica

What Is The Regional Outlook For The Global Polymyalgia Rheumatica Market?

What Defines the Polymyalgia Rheumatica Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Polymyalgia Rheumatica Industry?

Table Of Contents

List Of Tables

List Of Figures

How is the Allergy Diagnostics Market Poised for Growth: Trends and Opportunities Through 2034

Future Outlook of the Ambulatory Electronic Medical Records Market: Growth, Trends, and Emerging Opportunities Explored

Antimicrobial Susceptibility Testing Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

Assisted Reproductive Technology Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

How is the Bed Monitoring System & Baby Monitoring System Market Poised for Growth: Trends and Opportunities Through 2034

Growth Opportunities and Trends in the Biopharmaceutical CMO Market: Key Insights for 2025-2034

How Will the Bipolar Disorder Therapeutics Market Grow? Key Trends and Opportunities for 2025 and Beyond

Key Trends and Insights into the Bleeding Disorders Treatment Market: Growth Rate and Opportunities to 2034

Frequently Asked Questions